From: Bilateral primary angiosarcoma of the breast: a case report
 | WBC | Hb | Plt | BUN | Cre | ALP | AST | ALT | γGTP | LDH | Alb |
---|---|---|---|---|---|---|---|---|---|---|---|
First hospitalization | 4.62 | 12,4 | 282 | 10 | 0.54 | 62 | 13 | 9 | 8 | 158 | 3.9 |
Start of paclitaxel | 3.19 | 11.3 | 212 | 11 | 0.53 | 92 | 17 | 13 | 26 | 185 | 4.4 |
Start of doxorubicin | 4.46 | 10.8 | 278 | 8 | 0.49 | 112 | 36 | 30 | 60 | 195 | 4.3 |
1Â month after third HAIC | 3.11 | 7.9 | 116 | 12 | 0.49 | 237 | 129 | 196 | 284 | 305 | 4.1 |
Start of eribulin | 11.13 | 9.7 | 181 | 16 | 0.45 | 392 | 67 | 176 | 453 | 891 | 3.3 |
2Â weeks before first TAE | 8.66 | 9.1 | 127 | 18 | 0.47 | 338 | 49 | 128 | 442 | 763 | 3.3 |
Before first TAE | 7.06 | 2.7 | 65 | 21 | 0.47 | 117 | 25 | 50 | 217 | 275 | 2.6 |
Before second TAE | 7.14 | 5.2 | 84 | 16 | 0.43 | 270 | 46 | 36 | 346 | 605 | 2.0 |
Before third TAE | 10.23 | 6.4 | 94 | 18 | 0.45 | 566 | 115 | 84 | 585 | 1094 | 2.7 |
Before fourth TAE | 8.31 | 4.5 | 117 | 26 | 0.60 | 345 | 76 | 100 | 354 | 788 | 1.8 |
Before fifth TAE | 9.21 | 6.1 | 100 | 20 | 0.59 | 406 | 104 | 161 | 371 | 1147 | 2.2 |